Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis

NCT02743364 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Acute Pancreatitis

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Placebo Administration
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Simvastatin

Sponsor

National Cancer Institute (NCI)